| 2024 | 2023 | 2022 | 2021 | |||||
|---|---|---|---|---|---|---|---|---|
| Profit/loss | -1,3 M € | -262.6% | -347,1 k € | +66.9% | -1,0 M € | -397.6% | -210,8 k € | |
| Equity | 1,8 M € | -41.3% | 3,1 M € | -10.2% | 3,4 M € | -23.6% | 4,4 M € | |
| Gross margin | 146,9 k € | -77.2% | 644,1 k € | +121.9% | 290,3 k € | -69.0% | 936,3 k € | |
| Staff | 2,7 | 2 | 2,8 | 3 | ||||
Key indicators
| Unit no. | Name | Location |
|---|---|---|
| 2268464566 | B.C.I. Pharma | Avenue de l'Hôpital 11, 4000 Liège |
Public limited company · Liège · incorporated on 28/09/2017 · 2,7 ETP
Public limited company en perte sur le dernier exercice. Trésorerie en repli (-66.4 %).
Source: filing of 08/08/2025
7-day free trial, no credit card required.
Source: Belgian Official Gazette